Browse diseases

…ethods We collected 85 S. anginosus genomes: seven derived from gastric cancer (GC) patients (Zhou et al., 2026), one from a GC patient (Yuan …

…tamab vedotin (RC48), has been pivotal in rendering ‘HER-2-low’ gastric cancer (GC) a therapeutically targetable entity, expanding the populat…

…associated with upper GI cancer following a positive FIT and no colorectal cancer, inflammatory bowel disease or polyps on lower GI investigation…

…polyps, diverticular disease, angiodysplasia) in both groups. 1 gastric cancer was diagnosed in the pre-SOP group. Upper GI findings were note…

…n repeat OGD were analysed.Results A total of 221 patients with gastric ulcers were identified. Eight patients (3.6%) were diagnosed with gast…

…py effectively and can stratify patients based on their risk of colorectal cancer and other significant pathologies. Double-negative FIT individu…

… sub mucosal dissection (ESD) as a widely accepted approach for gastrointestinal cancer, there are many associated postoperative complications, includi…

…. Indications included hepatopancreatobiliary malignancy (63%), gastric cancer (11%), duodenal cancer (8%), metastatic disease (11%), and beni…

…eptococcus anginosus has been linked with an increasing risk of gastric cancer (GC) and recognised as a signature for GC screening.Objective T…

…Background The efficacy of chemo-immunotherapy in gastric cancer (GC) is limited by heterogeneous resistance and the lack of pre…

…B, et al. Preventive Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality: A Korean Population Study. Gastroenter…

… cancers (p<0.05), whereas no beneficial trend was detected for pancreatic cancer. Subgroup analyses indicated persistently lower screening parti…